NOTIFICATION  OF  THE  REMOVAL  FROM  LISTING  AND REGISTRATION OF THE STATED
SECURITIES

The American Stock Exchange LLC hereby notifies  the  SEC of its intention to
remove   the  entire  class  of  the  stated  securities  from  listing   and
registration on the Exchange at the opening of business on February 22, 2007,
pursuant to the provisions of Rule 12d2-2 (a). 17CFR240.12d2-2(a)(2)

The removal of Merrill Lynch & Co., Inc. Strategic Return Notes linked to the
Biotech-Pharmaceutical  Index,  maturing  February  8, 2007 is being effected
because the Exchange knows or is reliably informed that  the  entire class of
this security was redeemed or paid at maturity or retirement on  February  8,
2007.

The security was suspended by the Exchange on February 9, 2007.